Reviva Pharmaceuticals Holdings, Inc. expected to post a loss of 29 cents a share - Earnings Preview

Reviva Pharmaceuticals Holdings

09/08/2024 17:37

* Reviva Pharmaceuticals Holdings, Inc.  RVPH.OQ 
 RVPH.O  is
expected to show no change in quarterly revenue when it reports 
results on August 12 (estimated) for the period ending June
30 2024
    * 
    * ​LSEG's mean analyst estimate for Reviva Pharmaceuticals
Holdings, Inc. is for a loss of 29 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Reviva
Pharmaceuticals Holdings, Inc. is $15.00​, above​ its last
closing price of $0.85. ​​​

This summary was machine generated August 9 at 16:37 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)